Exhibit 10.18
Confidential Materials omitted and filed separately with the Securities
and Exchange Commission. Asterisks denote omissions.
FIRST AMENDMENT OF COLLABORATION AND
LICENSE AGREEMENT
This First Amendment of Collaboration and License Agreement (the "First
Amendment"), effective as of November 17, 2000, is made by and between Becton,
Xxxxxxxxx and Company, a corporation organized and existing under the laws of
New Jersey and having its principal office at 0 Xxxxxx Xxxxx, Xxxxxxxx Xxxxx,
Xxx Xxxxxx 00000 ("BD"), and Millennium Predictive Medicine, Inc., a corporation
organized and existing under the laws of Delaware and having its principal
xxxxxx xx Xxx Xxxxxxx Xxxxxx, Xxxxxxxxx, Xxxxxxxxxxxxx 00000 ("MPMx").
BD and MPMx are parties to a certain Collaboration and License
Agreement dated February 21, 1999 (the "Agreement").
BD and MPMx desire to amend a provision of the Agreement.
NOW, THEREFORE, BD and MPMx agree as follows:
1. The Additional Payment of [**] Dollars ($[**]) payable by BD to MPMx
on the second anniversary of the Effective Date, pursuant to Section 4.2 of the
Agreement, shall be deferred and become due and payable by BD to MPMx on October
1, 2001 in lieu of on February 21, 2001.
2. All other terms and conditions of the Agreement shall remain in full
force and effect. Further, the consent pertaining to the Agreement dated October
20, 2000 shall remain in full force and effect.
In WITNESS WHEREOF, BD and MPMx have executed this First Amendment as
of the date first set forth above.
BECTON, XXXXXXXXX AND COMPANY
By: /s/ XXXXXXX X. XXXXXXXX
---------------------------------
Xxxxxxx X. Xxxxxxxx
Senior Vice President Technology,
Strategy and Development
MILLENNIUM PREDICTIVE MEDICINE, INC.
By: /s/ XXXXXXX X. XXXXXX
---------------------------------
Xxxxxxx X. Xxxxxx, President
